These findings underscore the inhibitory effect of FGL1 knockdown on ESCC cell migration in vitro and its role in suppressing metastasis in vivo, supported by a decrease in the count of lung metastatic nodules in the xenograft model (Fig. 3F and G). Here, FGL1 is linked to esophageal squamous cell carcinoma.